Needham & Company Starts Clearside Biomedical (CLSD) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Cowen Starts Clearside Biomedical (CLSD) at Outperform
June 27, 2016 6:46 AM EDTCowen initiated coverage on Clearside Biomedical (NASDAQ: CLSD) with an Outperform rating.
For an analyst ratings summary and ratings history on Clearside Biomedical click here. For more ratings news on Clearside Biomedical click here.
Shares of Clearside Biomedical closed at $6.80 yesterday.
... MoreWedbush Starts Clearside Biomedical (CLSD) at Outperform, $28 PT
June 27, 2016 6:20 AM EDTWedbush initiates coverage on Clearside Biomedical (NASDAQ: CLSD) with a Outperform rating and a price target of $28.00.
Analyst Liana Moussatos commented, "We believe an investment in CLSD supports a dramatic improvement in injectable drug delivery for multiple eye diseases."
She added, "Clearside is a... More
